Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma
about
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusInhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.(1)H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen.HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma TherapyHinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.Vasculogenic mimicry in small cell lung cancer.Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradationAdvanced research on vasculogenic mimicry in cancerMelanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?Marketed drugs used for the management of hypercholesterolemia as anticancer armament.MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway.Overview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
Q26773795-88B00B2D-BDBC-4783-AB4D-20A579D71CBCQ26800615-4BB8B6D0-7A5A-452D-9579-23B7AACF5214Q33584252-45E1062E-E3B4-4782-B4B8-1EFD9DC06F45Q34453064-24C219C9-ACB6-4EA0-A16B-332744509DC8Q34750633-BAA1AEA3-6744-40BC-96DA-6A3DA6A43BB6Q36510844-F3CABE0E-1FCB-477E-AB44-2297C8B32314Q36742307-A40C8CE1-0EA2-4B73-BD67-64CB4A19BDD8Q37408684-7066AE05-E686-4E50-8FE7-09359B3BAB16Q37679063-615F7787-77D7-4C94-AC54-DDF698DD2C06Q38322795-1E3F7825-2046-4034-9F60-3BAC982FFC00Q39417544-790196D9-59FF-4CB2-BFB6-86884D76FC43Q41080847-842C6DFD-3714-40EE-9EFE-46912980F40BQ41472574-202B07B5-5A80-41CF-8F6C-34B706965932Q58803491-2702A032-33C9-48C5-9C7F-67F84196576B
P2860
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@ast
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@en
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@nl
type
label
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@ast
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@en
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@nl
prefLabel
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@ast
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@en
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@nl
P2093
P2860
P1433
P1476
Nicotinamide inhibits vasculog ...... in highly aggressive melanoma
@en
P2093
Avraham J Treves
Bruria Shalmon
Camilla Avivi
Eyal Greenberg
Eytan Ben-Ami
Gal Markel
Jacob Schachter
Michal J Besser
Orit Itzhaki
P2860
P304
P356
10.1371/JOURNAL.PONE.0057160
P407
P577
2013-02-25T00:00:00Z